Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.93 - $10.75 $50,019 - $278,607
-25,917 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$9.1 - $12.62 $235,844 - $327,072
25,917 New
25,917 $269,000

Others Institutions Holding ALLR

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Allarity Therapeutics, Inc.


  • Ticker ALLR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,260,200
  • Market Cap $2.05M
  • Description
  • Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; D...
More about ALLR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.